The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial
Type of Publication
Journal Article
Year of Publication
2012
Journal
Lancet
Language
Eng
ISBN Number
1474-547X (Electronic)0140-6736 (Linking)
Volume
379
Number of Pages
2352-63
Links to full text